BioCentury | Jul 20, 2018
Company News

Management tracks: Merck KGaA, Aeglea

...and deputy general counsel, corporate/M&A at Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA). The non-profit Familial Hypercholesterolemia Foundation...
BioCentury | Mar 17, 2017
Company News

Familial Hypercholesterolemia, Express Scripts news

...HoFH). Zetia is a cholesterol absorption inhibitor from Merck & Co. Inc. (NYSE:MRK, Kenilworth, N.J.). Familial Hypercholesterolemia Foundation...
...Express Scripts Holding Co. (NASDAQ:ESRX), St. Louis, Mo. Business: Endocrine/Metabolic Jaime De Leon alirocumab AMG 145 evolocumab ezetimibe Ezetrol Praluent REGN727 Repatha SAR236553 SAR236553/REGN727 Zetia Express Scripts Holding Co. Familial Hypercholesterolemia Foundation Merck...
BioCentury | Mar 17, 2017
Clinical News

Amgen sinks as CVOT results draw mixed payer reactions

...it "may make physicians more likely to prescribe the medications." Via a partnership with The Familial Hypercholesterolemia Foundation...
BioCentury | Mar 15, 2017
Company News

Express Scripts expanding PCSK9 coverage for FH patients

...The Familial Hypercholesterolemia Foundation (Pasadena, Calif.) said it partnered with Express Scripts Holding Co. (NASDAQ:ESRX) to expand the...
...cholesterol absorption inhibitor from Merck & Co. Inc. (NYSE:MRK). Jaime De Leon alirocumab AMG 145 evolocumab ezetimibe Ezetrol Praluent REGN727 Repatha SAR236553 SAR236553/REGN727 Zetia Amgen Inc. Express Scripts Holding Co. Familial Hypercholesterolemia Foundation Merck...
BioCentury | Feb 9, 2015
Company News

Amgen, Stanford University, FH Foundation deal

...to disclose financial terms. Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Stanford University , Stanford, Calif. Familial Hypercholesterolemia Foundation...
Items per page:
1 - 5 of 5
BioCentury | Jul 20, 2018
Company News

Management tracks: Merck KGaA, Aeglea

...and deputy general counsel, corporate/M&A at Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA). The non-profit Familial Hypercholesterolemia Foundation...
BioCentury | Mar 17, 2017
Company News

Familial Hypercholesterolemia, Express Scripts news

...HoFH). Zetia is a cholesterol absorption inhibitor from Merck & Co. Inc. (NYSE:MRK, Kenilworth, N.J.). Familial Hypercholesterolemia Foundation...
...Express Scripts Holding Co. (NASDAQ:ESRX), St. Louis, Mo. Business: Endocrine/Metabolic Jaime De Leon alirocumab AMG 145 evolocumab ezetimibe Ezetrol Praluent REGN727 Repatha SAR236553 SAR236553/REGN727 Zetia Express Scripts Holding Co. Familial Hypercholesterolemia Foundation Merck...
BioCentury | Mar 17, 2017
Clinical News

Amgen sinks as CVOT results draw mixed payer reactions

...it "may make physicians more likely to prescribe the medications." Via a partnership with The Familial Hypercholesterolemia Foundation...
BioCentury | Mar 15, 2017
Company News

Express Scripts expanding PCSK9 coverage for FH patients

...The Familial Hypercholesterolemia Foundation (Pasadena, Calif.) said it partnered with Express Scripts Holding Co. (NASDAQ:ESRX) to expand the...
...cholesterol absorption inhibitor from Merck & Co. Inc. (NYSE:MRK). Jaime De Leon alirocumab AMG 145 evolocumab ezetimibe Ezetrol Praluent REGN727 Repatha SAR236553 SAR236553/REGN727 Zetia Amgen Inc. Express Scripts Holding Co. Familial Hypercholesterolemia Foundation Merck...
BioCentury | Feb 9, 2015
Company News

Amgen, Stanford University, FH Foundation deal

...to disclose financial terms. Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Stanford University , Stanford, Calif. Familial Hypercholesterolemia Foundation...
Items per page:
1 - 5 of 5